<DOC>
	<DOCNO>NCT01693939</DOCNO>
	<brief_summary>The purpose study document program flap thickness achieve flap thickness use FS200 femtosecond laser perform LASIK procedure . The FS200 Femtosecond laser precision surgical device use create flap FDA approve LASIK procedure .</brief_summary>
	<brief_title>Evaluation Post-LASIK Flap Thickness FS200 Femtosecond Laser Flap</brief_title>
	<detailed_description>The objective study evaluate thickness corneal flap create FS 200 Femtosecond laser flap LASIK procedure use Visante OptiVue OCT ultrasound device .</detailed_description>
	<mesh_term>Myopia</mesh_term>
	<criteria>INCLUSION CRITERIA The following requirement potential study patient 's inclusion study : Male female good general health , 18 year age old time preoperative examination Patient must able read , comprehend willing give HIPPA inform consent Patient planning undergo bilateral LASIK procedure Both eye must manifest refractive error 1.00 7.00D spherical equivalent less equal 3.00 D refractive astigmatism express spectacle minus cylinder form Both eye must BSCVA 20/25 good Both eye must demonstrate refractive stability confirm clinical record previous glass . Refractive stability shall document change less equal 0.50 diopter per year ( sphere cylinder ) document clinical judgment investigator . EXCLUSION CRITERIA The following exclusion criterion study patient study : A patient evidence keratoconus , corneal irregularity , abnormal videokeratography either eye A patient require use ocular drop ( ) and/or medication ( ) either eye study period exception ocular drop and/or medication provide investigator A patient surgical procedure within week precede schedule LASIK surgery A patient UNCONTROLLED systemic disease ( i.e. , potential patient therapy systemic disease yet stabilize ) A patient history prior intraocular corneal surgery ( include cataract extraction ) , clinically significant ophthalmic disease abnormality ( include , limited , uncontrolled clinically significant blepharitis , clinically significant recurrent corneal erosion , clinically significant dry eye syndrome , clinically significant lens opacity , evidence clinically significant trauma ( include scar inside visual axis ) , evidence glaucoma propensity narrow angle glaucoma either eye A patient significant history current evidence medical , psychological disorder , investigator 's opinion , may increase risk associate study participation may interfere interpretation study result A patient history follow medical condition , condition could affect wound healing : uncontrolled diabetes , collagen vascular disease , autoimmune disease , immunodeficiency disease , ocular herpes zoster simplex , endocrine disorder ( include , limited unstable thyroid disorder diabetes ) , lupus , rheumatoid arthritis A female patient pregnant , nursing , plan pregnancy study , think may pregnant start study Current participation participation within 30 day prior start study drug investigational device research study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Lasik</keyword>
	<keyword>Myopia</keyword>
	<keyword>Femtosecond Laser</keyword>
</DOC>